TWI339176B - Protected vial, and method for manufacturing same - Google Patents

Protected vial, and method for manufacturing same Download PDF

Info

Publication number
TWI339176B
TWI339176B TW94133581A TW94133581A TWI339176B TW I339176 B TWI339176 B TW I339176B TW 94133581 A TW94133581 A TW 94133581A TW 94133581 A TW94133581 A TW 94133581A TW I339176 B TWI339176 B TW I339176B
Authority
TW
Taiwan
Prior art keywords
vial
bottle
envelope
label
protective
Prior art date
Application number
TW94133581A
Other languages
Chinese (zh)
Other versions
TW200619091A (en
Inventor
Vos Dick De
Original Assignee
Pharmachemie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL1027179A external-priority patent/NL1027179C2/en
Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv
Publication of TW200619091A publication Critical patent/TW200619091A/en
Application granted granted Critical
Publication of TWI339176B publication Critical patent/TWI339176B/en

Links

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Description

1339.176 九、發明說明: 【發明所屬之技術領域】 本發明係有關-種製造保護瓶的方法和_種可根據該方 法製造的保護瓶。 【先前技術】 藥瓶在醫療卫作中,經常被使用。藥瓶通常由-個盛裝醫 用藥液的容器組成,並且用一個可以用注射針穿透的塞子 塞住。這種藥瓶通常還包括一個保護蓋’在使用之前需要 先去除。在生產這種藥瓶的方法中,藥液很有可能會溢出 二瓦外。因此’填滿及密封藥瓶後,需沖洗藥瓶以去除瓶外 的液體。然而,從實務上已知,藥瓶的外壁未必乾淨,所 謂乾淨也就是說未遭受活性物質污染。在這種情況下,沖 洗並未徹底地將活性物質 留。 1初 > 去除’而仍有微量的活性物質殘 士ά ϊ ’舌性物質的殘留i甬食$合# #& 此 的殘留通予不會構成嚴重的問題,但在某 二馆况下’例如對制細 了。例如衆… 抗生素而5,情況就不同 得較p及華总 制細胞劑會吸附在玻璃上。這可能使 :及料的職員在處理這些藥瓶時接觸 -毒性的物質。如果是抗生素,其在藥瓶外 望發生的,K s a, 1 $J J木疋不希 的抗生素接觸 唧诸院和樂房職員攜帶的微生物時, 微生物對有_生素加㈣㈣^ 可此導致 【發明内容】 本發明之一舌 要目的是消除以上所述的種種缺失,從而 105022.doc U39176 避免其帶來的負面後果。所以,本發明 護瓶的方法,皇中在藥 ’、’、 製造保 ,、τ在樂瓶被填充後周圍會 套,其中對著藥瓶的底部會有 、-己封 〜*丄 门& 口丨知戴,以及苴φ r左 ^ —緊配套管將至少藥瓶的整個側壁包住,η 圓周圍邊緣與底部的標籤部分重疊。 並〉。底部 因此’藥瓶沖洗後可能殘留在藥 ”瓶和緊配封套間,此封套分兩部包在藥瓶 底部的標藏和一個緊配套管。心,使用者就: 於有毒物質下,因爲使用去胳尤公社 再暴路 用者將不會接觸藥瓿本身,而是接 觸藥瓶的封套。因禹蘿& 44太& + , 田走人 樂瓶封套緊抗地將藥瓶環繞,所以使 用時會保有正常的,,觸感",因此其 &,、運步的細作和處理就 1:: 一樣。就發展抗藥性而言,微生物現在就沒有機會 接觸樂瓶外的微量抗生素。另—個優勢是,如果藥瓶破 了 1瓶封套仍然可以將破璃碎片包在一起,從而可能避 免藥液渗漏出來。 此防護性封套的使用是在填充藥舰之後;在密封藥瓶之 步驟之後更佳。 較好,底部標^自枯的,會緊密地點在藥瓶的底部。 本發明之-較佳具體實施财,緊配套管(其爲緊配封套 $ π π ϋ且會覆蓋至少藥瓶的整自外壁)是由合成材 料製成。套管滑過藥瓶只有很小的空f01,並且在施加熱的 情況下使其縮小’因而會緊配在藥瓶的外圍。 兹注意到,在藥瓶外包-個緊配封套的方法見於美國專 利第3 82“59號。根據該已知方法,一個填充並密封的藥 '05022.doc 瓶被放置在一合成的封套 封套包括-個费一, 于套党熱的影響而收縮。此 ㈤覆盍樂觀底部的底層部份,和 樂瓶外壁的直立圓柱狀的用來覆-護蓋。 以及—個位於藥瓶上的保 依照已知的方法,封套一 片式包在藥瓶外圍’其構成 ί相對本發明方法的主, .u , ^ ^ ,、根據本發明方法,封套以 耍4㈤ 丁截^個套官。如此設計的重 要優點疋,包圍藥瓶封套的方法被簡化了。而且,比起一 個含底部和由底部延伸之 圓柱狀4刀的封套,底部標籤和 圓柱狀套官更容易生産。 再者,當應用已知方法時,藥瓶 “皮推入-端封閉的封套中,這就比將一個套管拉過瓶子 要困難的夕’因爲空氣需要被麼出封套,而供空氣溢出的 空間又很小。此外’當封套在藥瓶上收縮時,空氣有可能 留在^套和藥瓶之間。當封套以兩步驟裝配時,該等不利 效果就不會發生’其中第一步驟包括將底部標藏貼在藥瓶 的&卩而其中第一步驟包括將套管環繞在藥瓶外圍並使 八在藥瓶上收縮,其中套管所在的位置是可以包裹藥瓶的 外壁’並且與底部標籤沿瓶底圓周的邊緣部分重疊。 【實施方式】 本發明的各種態樣、特徵和優點將由以下的敘述’參考 附圖作進一步地說明。 圖1中’係顯示本發明經填充和密封後之保護瓶1的橫截 面圖。此保護瓶丨由本身已知含侧壁2〇丨的玻璃藥瓶2、底 4 202和取用口 3所組成。藥瓶2中,已存在有藥液7。保護 I05022.doc 以及一個保護 =具有-個可刺穿的密封膜4,例如橡膠 盍5,例如金屬。 在藥瓶2的外壁上,主+卷 m aw l 緊配地覆蓋幾乎整個藥瓶2, W墁盍5除外。封叁& a社 沲2姑广, 套6包括一個底部標籤602,其覆蓋藥 、氐。P 202 ;以及一個套管 ^ ^ 、 ^ .a .. 其覆蓋側壁201並且與 底礼戴602沿瓶底2〇2圓周邊緣有部分的重叠。 與 ρνίΓΓ·1較好是由透明的合成材料製成,例如ΡΕ、ΡΡ、 的八成Ml似物的膜。此外,底部標籤6。2較好亦由透明 的合成材料製作而成。 成而且,底部標籤602較好是自粘 仁疋,在本發明的範圍内這並非必要條件。 套管601的合谪厘# Β 古 又值疋〇.05毫米;但該厚度值也可較 同或較低。底部標箍 ,、紙602的厚度較佳為約〇15毫米的 以比楚起見,圓1中之保護瓶1的某些部分的厚度茲 以比較绔張的方式顯示。 保護⑹是按照以下步驟製造,以簡化方 £中。首先提供空藥瓶以太身支口 Α、 (本身為已知)(圖2Α)。然後將該藥 瓶2透過取用口 3填充入銥 、 兄入樂液7(圖2B)。接著,用密封膜4貼 住取用口 3 ’再裝上保護蓋5(圖2C)。然後,沖洗整個藥 、便去除填充過程中可能溢出留在藥瓶2外部的藥 液。隨後’在藥瓶2的底部202貼上合成的底部標籤6〇2, 將合成的套管6G1滑過藥瓶2(圖2D)。最後的步驟是,將套 管60 1進行熱處理,灼 攸而使其收縮而緊緊環繞在藥瓶2的四 周(圖2E)。 九長:供έ套管6〇 1和底部標籤602的藥瓶2對藥瓶 105022.doc 1339176 外部污染的影響,進行了一系列的試驗(Report f()l_1339.176 IX. DESCRIPTION OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to a method of manufacturing a protective bottle and a protective bottle which can be manufactured according to the method. [Prior Art] Pill bottles are often used in medical care. The vials are usually made up of a container containing the medical fluid and plugged with a stopper that can be pierced with an injection needle. This vial usually also includes a protective cover that needs to be removed before use. In the method of producing such a vial, the liquid is likely to overflow beyond two watts. Therefore, after filling and sealing the vial, the vial needs to be rinsed to remove the liquid outside the vial. However, it is known from practice that the outer wall of the vial is not necessarily clean, so that it is clean and that it is not contaminated with active substances. In this case, the washing does not completely leave the active material. 1 initial > remove 'and there are still traces of active substance residue ά ϊ 'Residue of tongue substance i $食#合# #& This residual pass does not pose a serious problem, but in a certain two conditions The next 'for example, the system is fine. For example, the public... Antibiotics, 5, the situation is different than the p and Hua total cytotoxic agent will be adsorbed on the glass. This may allow the staff of the materials to contact the toxic substances when handling these vials. If it is an antibiotic, it is expected to occur outside the vial, K sa, 1 $JJ 疋 的 antibiotics contact with the microorganisms carried by the hospitals and staff of the house, the microbes have _ 素 素 (4) (4) ^ can cause [ SUMMARY OF THE INVENTION One of the objects of the present invention is to eliminate the above-mentioned various defects, thereby avoiding the negative consequences of 105022.doc U39176. Therefore, the method of protecting the bottle of the present invention, Huangzhong in the medicine ', ', manufacturing warranty, τ will be wrapped around the bottle after the bottle is filled, which will be at the bottom of the bottle, there is ~ ~ 丄 && The mouth is known to wear, and the 苴φ r left ^ - tight matching tube will wrap at least the entire side wall of the vial, and the surrounding edge of the η circle overlaps the label portion of the bottom portion. and>. The bottom is therefore between the bottle may be left in the medicine bottle and the tightly fitted envelope. The envelope is divided into two parts that are wrapped in the bottom of the bottle and a tight matching tube. The heart, the user: Under the toxic substance, because If you use the squad to get rid of the sputum, you will not touch the medicinal sputum itself, but the cover of the vial. Because the dill & 44 too & +, the stalker bottle cover tightly surrounds the vial Therefore, the use will maintain normal, touch sense, so its &, the operation of the step and the processing is 1:: In terms of development of resistance, microorganisms now have no chance to contact the outside of the bottle A small amount of antibiotics. Another advantage is that if the bottle breaks a bottle of envelopes, it can still wrap the broken pieces together, which may prevent the liquid from leaking out. This protective envelope is used after filling the medicine ship; Preferably, the step of sealing the vial is better. Preferably, the bottom mark is self-drying and will be closely located at the bottom of the vial. The present invention is preferably a specific implementation, which is a tightly fitting envelope (which is a tightly fitted envelope $ π π And will cover at least the entire bottle ) is made of synthetic material. The sleeve slides over the vial with a small empty space f01 and is reduced by the application of heat 'and thus fits tightly around the vial. It is noted that the vial is outsourced. A method of tightly fitting an envelope is found in U.S. Patent No. 3,82,59. According to the known method, a filled and sealed drug '05022.doc bottle is placed in a synthetic envelope envelope including a fee of one, shrinking under the influence of the set party heat. This (5) covers the bottom part of the optimistic bottom, and the upright cylindrical shape of the outer wall of the bottle is used for covering-covering. And a method on the vial according to the known method, the envelope is wrapped in a piece on the periphery of the vial 'the composition of the method relative to the method of the invention, .u , ^ ^ , according to the method of the invention, the envelope is used to play 4 (five) Ding cut a set of officials. The important advantage of this design is that the method of enclosing the vial envelope is simplified. Moreover, the bottom label and the cylindrical sleeve are easier to produce than an envelope with a bottom and a cylindrical 4 knife extending from the bottom. Furthermore, when the known method is applied, the vial is pushed into the closed-end envelope, which is more difficult than pulling a sleeve through the bottle because the air needs to be removed from the envelope and the air is spilled. The space is very small. In addition, when the envelope shrinks on the vial, the air may remain between the sleeve and the vial. When the envelope is assembled in two steps, the adverse effects will not occur. The step includes attaching the bottom label to the &<>> of the vial and wherein the first step comprises wrapping the sleeve around the periphery of the vial and allowing the eight to contract on the vial, wherein the sleeve is located at the outer wall of the vial 'and overlapping with the bottom label along the edge of the circumference of the bottom of the bottle. [Embodiment] Various aspects, features and advantages of the present invention will be further described by the following description with reference to the accompanying drawings. A cross-sectional view of the filled and sealed protective bottle 1. The protective bottle is composed of a glass vial 2 having a side wall 2, a bottom 4202 and a access port 3. The vial 2 has been There is a liquid 7. Protect I05022.doc to And a protection = having a pierceable sealing film 4, such as a rubber crucible 5, such as a metal. On the outer wall of the vial 2, the main + roll m aw l tightly covers almost the entire vial 2, W墁盍Except for 5, the seal & a community 2 2, the cover 6 includes a bottom label 602 covering the medicine, 氐. P 202 ; and a sleeve ^ ^ , ^ .a .. which covers the side wall 201 and the bottom The dressing 602 has a partial overlap along the circumferential edge of the bottle 2 〇 2. The ρνίΓΓ·1 is preferably made of a transparent synthetic material, such as a film of ΡΕ, ΡΡ, and 80% Ml. In addition, the bottom label 6. 2 is preferably also made of a transparent synthetic material. Moreover, the bottom label 602 is preferably self-adhesive, which is not a requirement within the scope of the present invention. The combination of the casing 601 is 又疋〇.05 mm; but the thickness value can also be the same or lower. The bottom standard hoop, the thickness of the paper 602 is preferably about 15 mm, in comparison with the Chu, the protection bottle 1 in the circle 1 The thickness of these parts is shown in a more arrogant manner. The protection (6) is manufactured according to the following steps to simplify the process. First, provide the empty vial of the etheric bottle, (which is known per se) (Fig. 2Α). Then fill the vial 2 through the access port 3 into the sputum, brothers into the liquid 7 (Fig. 2B). The sealing film 4 is attached to the access opening 3' and then the protective cover 5 is attached (Fig. 2C). Then, the entire medicine is rinsed to remove the liquid medicine which may overflow the outside of the vial 2 during the filling process. Then 'in the vial 2 The bottom portion 202 is affixed with a synthetic bottom label 6〇2, and the synthetic sleeve 6G1 is slid over the vial 2 (Fig. 2D). The final step is to heat treat the sleeve 60 1 and burn it to shrink and tighten It is tightly wrapped around the vial 2 (Fig. 2E). Nine lengths: the vial of the sputum cannula 6〇1 and the bottom label 602 is subjected to a series of tests on the effect of external contamination on the vial 105022.doc 1339176 ( Report f()l_

Pharmachemie BV,Haarlem,紐西蘭,by Exp0sure C〇ntr〇1 BV, Wijchen, The Netherlands and University Medical Center Nijmegen,Nijmegen,紐西蘭),期間係測量包含順 氣氨鉑(cisplatin)的保護瓶1和無防護藥瓶的外部污染物。 藥瓶外部的萃取物被破壞生成鉑,然後用剝除伏安法 (Metrohm Application Bulletin No· 220/1。利用制除伏安法 測出超微量的始)分析。試驗細筘列於丁主ΑPharmachemie BV, Haarlem, New Zealand, by Exp0sure C〇ntr〇1 BV, Wijchen, The Netherlands and University Medical Center Nijmegen, Nijmegen, New Zealand), measuring the protective bottle containing cisplatin 1 And external contaminants from unprotected vials. The extract from the outside of the vial was destroyed to form platinum, which was then analyzed by stripping voltammetry (Metrohm Application Bulletin No. 220/1. Using the voltammetry to measure the ultra-micron). The test details are listed in Ding

試驗藥瓶被放入單一容φ。咕六。。成丄丄 0中 6亥今态填充有0.5 Μ的鹽 酸,將藥瓶完全浸沒。將容玛私 ^ ^ ^ ^ 竹谷益封閉,超音波處理30分鐘 後’將藥瓶從容器中取出。护立,士南m % s波處理過程中,藥瓶外的 順氣氨鉑污染物假設被溶解在鹽酸溶劑中。 樣品的預處理和以刻除彳φ 0 a u、 ^ 除伏女法的分析都是按照標準程序 進行。1毫升順氣氨鉑萃 取物以過氧化氫' 甲醛和紫外光 使破壞生成麵錯合物’ g而w二、z θ ^ 因而形成姑(pt)。衆所周知的事實 疋’順氯氣j自含有約6 5 %沾 的鉑。鉑的分析重覆作三次,相 對私準偏差爲2-3%。拾制认』 “的極限爲】〇奈克/升的萃取物。 105022.doc 了到高濃度樣品’樣品則稀釋後再分析。十個空白樣品 (空藥瓶)亦經萃取、分析並與順氣氨舶的藥瓶作比較,用 來校正链(50奈克/升萃取物)的背景值。 將從保護瓶!和無防護藥瓶2上發現之污染物的絕對數值 (匕如)用Wilc〇x〇n試驗進❸匕較。此試驗同樣適用於單 位面積上的污染物值(Pt_area),污染物值和藥瓶的内含物 匕外/内)有關且與所有作過空白校正的數值有關。p 值爲〇.〇5或以下被認爲有意義。數據以中位數、範圍和四 分位數為特徵。 試驗結果列於下表中 批次 無防護藥瓶 保護瓶 PT-area (奈克/厘 米平方)The test vial is placed in a single volume φ. Six. . In the case of Chengyu 0, the 6-year-old state is filled with 0.5 盐 of hydrochloric acid, and the vial is completely immersed. The Rongma private ^ ^ ^ ^ Zhu Guyi was closed, and after ultrasonic treatment for 30 minutes, the medicine bottle was taken out of the container. During the protection process, the ammonia-platinum contamination of the cis-gas outside the vial is assumed to be dissolved in the hydrochloric acid solvent. The pretreatment of the sample and the analysis of the 彳φ 0 a u, ^ volts method were performed according to standard procedures. 1 ml of the cis-ammonia platinum extract was hydrolyzed with hydrogen peroxide 'formaldehyde and ultraviolet light to cause the formation of the surface complex ' g and w 2, z θ ^ thus forming a pt (pt). It is a well-known fact that 顺 'cis chlorine j contains about 65 % of platinum. The analysis of platinum was repeated three times with a relative private bias of 2-3%. Pick up the recognition "The limit is 〇Nike / liter of extract. 105022.doc to the high concentration of the sample 'samples are diluted and then analyzed. Ten blank samples (empty bottles) are also extracted, analyzed and Compare the bottle of Shunqi ammonia to correct the background value of the chain (50 Ng / liter of extract). The absolute value of the contaminant found on the protective bottle! and the unprotected vial 2 (for example) Use Wilc〇x〇n test to compare 污染物. This test is also applicable to the pollutant value per unit area (Pt_area), the value of the pollutant is related to the contents of the vial (within/outside) and is blank It is related to the corrected value. The value of p is 〇.〇5 or less. It is considered to be meaningful. The data is characterized by median, range and quartile. The test results are listed in the table below. Batches without protective bottle protection bottle PT -area (Nike/cm squared)

Pt-abs PT-area (奈克)(奈克/厘米平方)Pt-abs PT-area (Nike/cm square)

Pt-abs (奈克)Pt-abs (Nike)

* BV=背景值 從上表,尤其是中位數的數據,可以清楚地看到,對於 保護瓶1,所有的參數都顯著低於無防護藥瓶2者。這證明 包含封套6的藥瓶2使藥瓶2外部的污染顯著地下降。 爲了研究具有套管601和底部標籤6〇2的藥瓶2對因而獲 得之保護瓶】意外掉落風險的影響,茲進行以下的掉落試 驗(Report for Pharmachemie BV,Haarlem,紐西蘭吻 I05022.doc 1339176* BV = background value From the above table, especially the median data, it can be clearly seen that for the protective bottle 1, all parameters are significantly lower than those without the protective bottle 2. This proves that the vial 2 containing the envelope 6 causes a significant drop in the contamination outside the vial 2. In order to investigate the effect of the bottle 2 with the cannula 601 and the bottom label 6〇2 on the risk of accidental dropping of the protective bottle obtained, the following drop test was performed (Report for Pharmachemie BV, Haarlem, New Zealand Kiss I05022) .doc 1339176

Topa Irmituut,Voorh〇Ut,紐西簡;叫州 τ〇4 1 0 6 8)。所應用的試驗流程由以下部分組成: 1) 墜落高度為120厘米的墜落試驗 本試驗的進行為模擬保護瓶1從桌面意外掉落到醫院的 地板上。^落高度爲120厘米’藥瓶著地位置是隨機的(頂 部,底部或側面)。藥瓶墜落的表面是模擬醫院地板的,,亞 麻油地氈"板。三種不同型號的藥瓶,即1〇毫升' 5〇毫升 和1 00毫升的藥瓶分別進行5次的墜落試驗。 2) 墜落高度為185厘米的墜落試驗 本試驗用以觀察當保護瓶丨從架子上掉到醫院地板上時 會有什麼狀況發生。墜落高度爲185厘米,藥瓶著地位置 是隨機的(頂部,底部或側面)。藥瓶掉落的表面是上述的” 亞麻油地熟"板。 掉落高度為120厘米之墜落試驗的結果列於下表中。爲 完備起見’可注意到地是,纟表中,保護瓶i指的是有覆 蓋的藥瓶,而無防制瓶2(即無封套6的隸2)指的是無覆 蓋的藥瓶。 墜落高度120厘米 ~ 10毫升 藥瓶 50毫升 藥瓶 100毫升 藥瓶 有覆蓋 無覆蓋 有覆蓋 無覆蓋 有覆蓋 結果 無覆蓋 結果 結果 結果 結果 結果 底部 著地 1 ok ok ok ok ok ok 105022.doc 1339176 2 ok ok ok ok ok ok 頂部 著地 1 ok ok ok ok ok ok 2 ok ok ok ok ok ok 側面 著地 1 ok ok ok ok ok ok 完整性 百分比% 100% 100% 100% 100% 100% 100% 墜落高度為1 85厘米的墜落試驗結果列於下表中。Topa Irmituut, Voorh〇Ut, New Zealand Jane; called State τ〇4 1 0 6 8). The test procedure applied consisted of the following: 1) Drop test with a drop height of 120 cm This test was carried out to simulate the protective bottle 1 accidentally falling from the table to the floor of the hospital. ^The drop height is 120 cm. The position of the vial is random (top, bottom or side). The surface of the drop bottle is simulated on the hospital floor, linoleum " board. Three different types of vials, ie 1 cc '5 〇 ml and 100 cc bottles, were tested for 5 drops respectively. 2) Drop test with a drop height of 185 cm This test is used to observe what happens when the protective bottle is dropped from the shelf onto the hospital floor. The drop height is 185 cm and the position of the vial is random (top, bottom or side). The surface of the drop bottle is the above-mentioned "linseed oil" plate. The results of the drop test with a drop height of 120 cm are listed in the table below. For the sake of completeness, it is noted that in the table, The protective bottle i refers to the covered medicine bottle, and the non-proof bottle 2 (ie, the 2 without the envelope 6) refers to the uncovered medicine bottle. Falling height 120 cm ~ 10 ml medicine bottle 50 ml medicine bottle 100 ML vial has coverage without coverage, no coverage, no coverage, no coverage, no results, results, results, bottom results, 1 ok ok ok ok ok ok ok 105022.doc 1339176 2 ok ok ok ok ok ok top landing 1 ok ok ok ok Ok ok 2 ok ok ok ok ok ok Side landing 1 ok ok ok ok ok ok Integrity percentage % 100% 100% 100% 100% 100% 100% The drop test results with a drop height of 1 85 cm are listed in the table below. .

墜落高度185厘米 10毫升 藥瓶 50毫升 藥瓶 100毫升 藥瓶 具覆蓋 無覆蓋 具覆蓋 無覆蓋 具覆蓋 無覆蓋 結果 結果 結果 結果 結果 結果 底部 著地 1 ok ok ok ok ok ok 2 ok ok ok ok ok ok 3 破碎 ok ok ok ok ok 4 ok ok ok ok 破碎 ok 5 ok ok ok ok ok ok 6 ok ok ok ok - - 7 ok ok ok ok - 8 ok 破碎 ok ok - - 9 ok ok ok ok - - 10 ok ok ok ok - - I05022.doc 12 1339176Falling height 185 cm 10 ml vial 50 ml vial 100 ml vial covered with no cover Covered without cover Covered without coverage Results Results Results Results Results bottom landing 1 ok ok ok ok ok ok 2 ok ok ok ok ok Ok 3 broken ok ok ok ok ok 4 ok ok ok ok broken ok 5 ok ok ok ok ok ok 6 ok ok ok ok - - 7 ok ok ok ok - 8 ok broken ok ok - - 9 ok ok ok ok - - 10 Ok ok ok ok - - I05022.doc 12 1339176

頂部 著地 1 ok ok ok ok ok ok 2 ok ok ok ok ok ok 3 ok ok ok ok ok ok 4 ok ok ok ok ok ok 5 ok ok ok ok ok ok 6 ok ok ok ok - - 7 ok ok ok ok - - 8 ok ok ok ok - - 9 ok ok ok ok - - 10 ok ok ok ok - - 側面 著地 1 ok ok 破碎 破碎 破碎 破碎 2 ok ok 裂縫 ok 破碎 破碎 3 ok ok ok 破碎 破碎 破碎 4 ok ok ok ok 破碎 破碎 5 ok ok ok ok 破碎 破碎 6 ok ok ok 破碎 裂縫 ok 7 ok ok 裂縫 ok 裂縫 破碎 8 ok ok 裂縫 ok ok 破碎 9 ok ok ok ok 裂縫 破碎 10 ok ok ok ok 破碎 破碎 105022.doc -13 - 1339176 完整性 百分比% 96,7% 96,7% 86,7% 90,0% 50,0% 50,0% 從墜落試驗的結果可以得結論是,具有套管6〇1和底部 標籤罐對藥瓶2抗破壞的性能沒有增強的保護。然而,此 藥航2遭受破壞時,經常會出現裂縫,而不是破碎。再 者此藥瓶2纟破碎或有裂縫時,5 〇%的情況下,藥瓶2 仍然能裝住其内容物。料無防護藥瓶2而言,所有被破 壞的情況下’其内容物都會濺灑在地板上。因&,、结論是 套管州和底部標蕺602的應用可以使藥瓶的處理更安全。 、上所述具體實;例僅僅是本發明的可能性例證。盆他 的變更和調整也都可能包含在所㈣請專利範圍定義:本 發明的保護範圍内。 …一似风里罘孜所巧染,例 如細胞抑制劑或抗生素,其可能在填充時溢出而灌在藥疏 2一的外部,因此在生産過程的最後一步驟中係對藥瓶2裝配 一個緊配的保護封套6。此封套6包括—個底部#籤6〇2, 其貼在藥瓶2的底部202’以及一個緊配套管⑹,Α收縮 於藥瓶2的側壁201,同時與底部標籤6〇2沿藥瓶2的底部 〇二周邊緣有部分重疊。由於封套6的配置,殘留於藥瓶Top landing 1 ok ok ok ok ok ok 2 ok ok ok ok ok ok 3 ok ok ok ok ok ok 4 ok ok ok ok ok ok 5 ok ok ok ok ok ok 6 ok ok ok ok - - 7 ok ok ok ok - - 8 ok ok ok ok - - 9 ok ok ok ok - - 10 ok ok ok ok - - Side landing 1 ok ok broken broken broken 2 ok ok crack ok broken broken 3 ok ok ok broken broken broken 4 ok ok Ok ok broken broken 5 ok ok ok ok broken broken 6 ok ok ok broken crack ok 7 ok ok crack ok crack broken 8 ok ok crack ok ok broken 9 ok ok ok ok crack broken 10 ok ok ok ok broken broken 105022.doc - 13 - 1339176 Integrity Percentage % 96,7% 96,7% 86,7% 90,0% 50,0% 50,0% From the results of the drop test it can be concluded that it has a casing 6〇1 and a bottom label The cans have no enhanced protection against the damage resistance of the vial 2. However, when this drug flight 2 is damaged, cracks often occur instead of being broken. In the case where the vial is broken or cracked, the vial 2 can still hold its contents in the case of 5 %. In the case of unprotected pill 2, all contents are spattered on the floor. Because &, the conclusion is that the application of the cannula state and the bottom standard 602 can make the treatment of the vials safer. The above is a concrete example; the examples are merely illustrative of the possibilities of the present invention. The changes and adjustments may also be included in the scope of the patent scope definition: within the scope of protection of the present invention. ...like a smudge of the wind, such as a cytostatic or antibiotic, which may overflow during filling and fill the outside of the drug, so in the final step of the production process, a bottle 2 is assembled. A tightly fitted protective envelope 6. The envelope 6 includes a bottom # sign 6〇2 attached to the bottom 202' of the vial 2 and a tight matching tube (6) which is shrunk to the side wall 201 of the vial 2 while the bottom label 6〇2 is along the vial The bottom of the 2 〇 two-week edge has a partial overlap. Remaining in the vial due to the configuration of the envelope 6

外。P的可能污染物就會被密封於藥瓶2和封套6之間。P ^姐使用者就不再會暴^有毒物質下,因爲使用者將: β接觸藥瓶2本身,而是接觸封套6。 # . ^ L 一 叹有封套6的另一個 二〇果樂瓶2破碎的話’封套6將會把破璃碎片包 在—起’並且可防止藥液7漏出。 * 〇5〇22.d〇c 1339176 【圖式簡單說明】 圖1顯示本發明之保護瓶的橫載面圖,以及 圖2A-E為製造圖1之保護瓶的連續步驟圖解。 【主要元件符號說明】 1 保護瓶 2 藥瓶 3 取用口 4 密封膜 ® 5 保護蓋 6 封套 7 藥液 201 側壁 202 底部 601 套管 602 底部標籤 105022.docouter. Possible contaminants of P will be sealed between the vial 2 and the envelope 6. The user of P^ will no longer be violently toxic, because the user will: β contact the vial 2 itself, but contact the envelope 6. # . ^ L 一 另一个 另一个 另一个 另一个 另一个 另一个 另一个 另一个 〇 〇 〇 另一个 另一个 ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ * 〇5〇22.d〇c 1339176 BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 shows a cross-sectional view of a protective bottle of the present invention, and Figs. 2A-E are diagrams showing successive steps of manufacturing the protective bottle of Fig. 1. [Main component symbol description] 1 Protective bottle 2 Pill bottle 3 Access port 4 Sealing film ® 5 Protective cover 6 Envelope 7 Liquid medicine 201 Side wall 202 Bottom 601 Sleeve 602 Bottom label 105022.doc

Claims (1)

13391761339176 第094丨33581號專利申請案 .中文申請專利範圍替換本(99年ι〇月) 十、申請專利範圍: 1. 一種製造保護瓶(1)的方法,包括以下步驟: -提供一藥瓶(2),其包括側壁(201),底部(202)和取用 〇 (3); -將藥液(7)填充入藥瓶(2); -用密封膜(4)貼住該取用口(3); _在藥瓶(2)填充步驟完成後,或在貼上密封膜(句的步 驟之後,在藥瓶(2)的四周圍上一緊配封套(6),且其 中對藥瓶(2)的底部(2〇2)配置一底部標籤(6〇2),隨後 配置一緊配套官(6〇1),用來至少包住藥瓶的整個 側壁(201) ’同時沿底部(2()2)圓周邊緣處與底部的標 籤(602)有部分的重疊。 2. 如請求項丨之方法,其中封套(6)的裝配步驟係在貼上密 封膜(4)的步驟之後。 3. 如β求項】或2之方法’其中將一保護蓋⑺貼附在密封膜 ⑷上。 士求項3之方法,其中在配置封套(6)的過程中,鬆開 保護蓋(5)。 如叫求項1或2之方法,其中套管(6〇丨)是由合成材料製 成,並且幾乎無縫隙的滑過藥瓶(2),且其中隨後進行熱 處理依此方式,套管(60 1)會收縮,從而緊配在藥瓶 . (2)的四周。 6·種保護瓶(丨)’包含一個具有側壁(201)和底部(202)的 經填充和密封藥瓶(2),其中在該經填充和密封藥瓶(2) 105022-991008.doc 1339176 .(^存^月丨I卜.丨 *頁 一一----—- 的四周配置一緊配封套(6) ’且其尹封套(6)包括一緊配 套管(6〇〗)和底部標籤(602),其中底部標籤(6〇2)貼在藥 瓶(2)的底部(202)上,且其中套管(6〇υ配置於至少藥瓶 (2)的整個側壁(2〇丨),同時沿底部(2〇2)的圓周邊緣與底 部標籤(602)有部分的重疊。 ,” _ 士-奮求項6之保護瓶,其中藥)係以如請 中任一 从丄.. 9 1至5項 105022.991008.docPatent Application No. 094丨33581. Replacement of Chinese Patent Application (99 years ι〇月) X. Patent application scope: 1. A method for manufacturing a protective bottle (1), comprising the following steps: - providing a medicine bottle ( 2), which comprises a side wall (201), a bottom part (202) and a pick-up 〇 (3); - a filling liquid (7) into the vial (2); - a sealing film (4) is attached to the access opening ( 3); _ After the filling step of the vial (2) is completed, or after the sealing film is attached (the step of the sentence, the envelope (6) is tightly placed around the circumference of the vial (2), and the vial is (2) The bottom (2〇2) is equipped with a bottom label (6〇2), and then a tight matching officer (6〇1) is used to cover at least the entire side wall (201) of the vial 'at the same time along the bottom ( 2() 2) There is a partial overlap with the label (602) at the bottom of the circumference. 2. The method of claim 2, wherein the assembly step of the envelope (6) is after the step of attaching the sealing film (4). 3. As in the method of β or the method of 2, in which a protective cover (7) is attached to the sealing film (4). The method of claim 3, wherein in the process of arranging the envelope (6), loosening A protective cover (5). The method of claim 1 or 2, wherein the sleeve (6〇丨) is made of a synthetic material and slides through the vial (2) almost without gaps, and wherein the heat treatment is subsequently performed In this way, the cannula (60 1) will contract so as to fit tightly around the vial. (2) 6. The protective bottle (丨) contains a filled and filled wall (201) and bottom (202) Sealing the vial (2), which is placed around the filled and sealed vial (2) 105022-991008.doc 1339176. (^存^月丨I卜.丨*页一一------ Tightly fitted with the envelope (6) 'and its Yin envelope (6) includes a tight matching tube (6〇) and a bottom label (602), wherein the bottom label (6〇2) is attached to the bottom of the vial (2) (202) Above, and wherein the sleeve (6〇υ is disposed on at least the entire side wall (2〇丨) of the vial (2) while having a partial overlap with the bottom label (602) along the circumferential edge of the bottom (2〇2). , " _ 士 士 - strive for item 6 of the protective bottle, which medicine" is as follows, please take any of the 丄.. 9 1 to 5 items 105022.991008.doc
TW94133581A 2004-10-05 2005-09-27 Protected vial, and method for manufacturing same TWI339176B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1027179A NL1027179C2 (en) 2004-08-19 2004-10-05 Protected vial, and method for making it.

Publications (2)

Publication Number Publication Date
TW200619091A TW200619091A (en) 2006-06-16
TWI339176B true TWI339176B (en) 2011-03-21

Family

ID=45074774

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94133581A TWI339176B (en) 2004-10-05 2005-09-27 Protected vial, and method for manufacturing same

Country Status (1)

Country Link
TW (1) TWI339176B (en)

Also Published As

Publication number Publication date
TW200619091A (en) 2006-06-16

Similar Documents

Publication Publication Date Title
CA2576610C (en) Protected vial, and method for manufacturing same
US9598195B2 (en) Packaging structure and method for sterile packaging containers for substances for medical, pharmaceutical or cosmetic applications and methods for further processing of containers using this packaging structure
NO834397L (en) CONTAINER FOR SEPARATE STORAGE OF A STERILIZED POWDER FORM AND A STERILIZED LIQUID COMPONENT, AND A PROCEDURE FOR MANUFACTURING THE CONTAINER
DK2470147T3 (en) Bag for storage of therapeutic solution
US20070108205A1 (en) Protective outer enclosure for pharmaceutical vial
CN100396334C (en) Process to improve stability of pharmaceutical compsn
FR2839497A1 (en) PACKAGE FOR USE IN TRANSPORTING STERILE OBJECTS OR IN STERELIZING
JPH07165252A (en) Vial container
US9908682B2 (en) Storage of ampoules containing pharmaceutical formulations using a sealed container comprising an oxygen scavenger
TWI339176B (en) Protected vial, and method for manufacturing same
JPH044231B2 (en)
CN101044059B (en) Protective small bottle and manufacturing method thereof
CN218617868U (en) Assembly of nested multiple pharmaceutical or cosmetic packaging containers
US20040118802A1 (en) Safety seal for potent product
IES84254Y1 (en) Protected vial, and method for manufacturing same
IE20050541U1 (en) Protected vial, and method for manufacturing same
Mallu et al. Hold time stability studies in pharmaceutical industry: Review
JP2015063324A (en) Cap sterilization method
TWI846941B (en) Device and method for filling, plugging and capping of liquid medicine packaging bottle with protrusion
Jahan et al. Advancements in sterilization packaging systems: Ensuring patient safety
Dean Stability aspects of packaging
TW202110415A (en) Packaging bottle and packaging kit for injection, and filling, stoppering and capping device and method
Pal et al. The significance of pharmaceutical packaging and materials in addressing challenges related to unpacking pharmaceutical products
WHO Expert Committee on Specifications for Pharmaceutical Preparations General aspects of packaging
Okeke et al. Packaging Systems: Compendial Requirements